Cargando…

Role of Chronic Lymphocytic Leukemia (CLL)-Derived Exosomes in Tumor Progression and Survival

Chronic lymphocytic leukemia (CLL) is a B-lymphoproliferative disease, which consists of the abnormal proliferation of CD19/CD5/CD20/CD23 positive lymphocytes in blood and lymphoid organs, such as bone marrow, lymph nodes and spleen. The neoplastic transformation and expansion of tumor B cells are c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nisticò, Nancy, Maisano, Domenico, Iaccino, Enrico, Vecchio, Eleonora, Fiume, Giuseppe, Rotundo, Salvatore, Quinto, Ileana, Mimmi, Selena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557731/ https://www.ncbi.nlm.nih.gov/pubmed/32937811 http://dx.doi.org/10.3390/ph13090244

Ejemplares similares

Uncovering the Exosomes Diversity: A Window of Opportunity for Tumor Progression Monitoring
por: Maisano, Domenico, et al.
Publicado: (2020)

Phage-Displayed Peptides for Targeting Tyrosine Kinase Membrane Receptors in Cancer Therapy
por: Aloisio, Annamaria, et al.
Publicado: (2021)

Detection of chronic lymphocytic leukemia subpopulations in peripheral blood by phage ligands of tumor immunoglobulin B cell receptors
por: Mimmi, Selena, et al.
Publicado: (2020)

Insights about MYC and Apoptosis in B-Lymphomagenesis: An Update from Murine Models
por: Vecchio, Eleonora, et al.
Publicado: (2020)

Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay
por: Mimmi, Selena, et al.
Publicado: (2022)

IBTK Haploinsufficiency Affects the Tumor Microenvironment of Myc-Driven Lymphoma in E-myc Mice
por: Vecchio, Eleonora, et al.
Publicado: (2020)

Predominant VH1-69 IgBCR Clones Show Higher Expression of CD5 in Heterogeneous Chronic Lymphocytic Leukemia Populations
por: Maisano, Domenico, et al.
Publicado: (2021)

IBtkα Activates the β-Catenin-Dependent Transcription of MYC through Ubiquitylation and Proteasomal Degradation of GSK3β in Cancerous B Cells
por: Vecchio, Eleonora, et al.
Publicado: (2022)

The expression of inhibitor of bruton’s tyrosine kinase gene is progressively up regulated in the clinical course of chronic lymphocytic leukaemia conferring resistance to apoptosis
por: Albano, Francesco, et al.
Publicado: (2018)

Development of Cyclic Peptides Targeting the Epidermal Growth Factor Receptor in Mesenchymal Triple-Negative Breast Cancer Subtype
por: Nisticò, Nancy, et al.
Publicado: (2023)

IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis
por: Vecchio, Eleonora, et al.
Publicado: (2019)

Monitoring multiple myeloma by idiotype-specific peptide binders of tumor-derived exosomes
por: Iaccino, Enrico, et al.
Publicado: (2017)

Insights into Thymus Development and Viral Thymic Infections
por: Albano, Francesco, et al.
Publicado: (2019)

Metabolites Profiling of Melanoma Interstitial Fluids Reveals Uridine Diphosphate as Potent Immune Modulator Capable of Limiting Tumor Growth
por: Vecchio, Eleonora, et al.
Publicado: (2021)

The aftermath of the Merck's HIV vaccine trial
por: Iaccino, Enrico, et al.
Publicado: (2008)

Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients
por: Mimmi, S, et al.
Publicado: (2016)

Peptide-guided targeting of GPR55 for anti-cancer therapy
por: Mangini, Maria, et al.
Publicado: (2016)

CRL3(IBTK) Regulates the Tumor Suppressor Pdcd4 through Ubiquitylation Coupled to Proteasomal Degradation
por: Pisano, Antonio, et al.
Publicado: (2015)

IBTK Differently Modulates Gene Expression and RNA Splicing in HeLa and K562 Cells
por: Fiume, Giuseppe, et al.
Publicado: (2016)

Spotlight on a Short-Time Treatment with the IL-4/IL-13 Receptor Blocker in Patients with CRSwNP: microRNAs Modulations and Preliminary Clinical Evidence
por: Mimmi, Selena, et al.
Publicado: (2022)

Exosomal miRNAs as Potential Diagnostic Biomarkers in Alzheimer’s Disease
por: Manna, Ida, et al.
Publicado: (2020)

Editorial: Lymphoid cells and tumor microenvironment: a functional crosstalk
por: Mimmi, Selena, et al.
Publicado: (2023)

Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-κB
por: Fiume, Giuseppe, et al.
Publicado: (2013)

Not all lymphoid aggregates in chronic lymphocytic leukemia (CLL) patients are due to CLL!
por: Mahapatra, Lily, et al.
Publicado: (2021)

Revisiting Bacterial Ubiquitin Ligase Effectors: Weapons for Host Exploitation
por: Pisano, Antonio, et al.
Publicado: (2018)

Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
por: Odetola, Oluwatobi, et al.
Publicado: (2023)

Immunological aspects in chronic lymphocytic leukemia (CLL) development
por: García-Muñoz, Ricardo, et al.
Publicado: (2012)

Physiological Fitness and the Pathophysiology of Chronic Lymphocytic Leukemia (CLL)
por: Sitlinger, Andrea, et al.
Publicado: (2021)

Design and Characterization of a Peptide Mimotope of the HIV-1 gp120 Bridging Sheet
por: Schiavone, Marco, et al.
Publicado: (2012)

Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice
por: Fiume, Giuseppe, et al.
Publicado: (2015)

Rapid transitions in the standard of care for chronic lymphocytic leukemia (CLL)
por: Seymour, Erlene K.
Publicado: (2019)

Leukemia Cutis as an Early Presentation or Relapsing Manifestation of Chronic Lymphocytic Leukemia (CLL)
por: Aldapt, Mahmood B, et al.
Publicado: (2021)

Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index
por: Wang, Yucai, et al.
Publicado: (2021)

Appearance and Disappearance of Chronic Myeloid Leukemia (CML) in Patient with Chronic Lymphocytic Leukemia (CLL)
por: Payandeh, Mehrdad, et al.
Publicado: (2014)

Population Pharmacokinetics of Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma and Exposure–Response in CLL
por: Gibiansky, E, et al.
Publicado: (2014)

COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
por: Scarfò, Lydia, et al.
Publicado: (2020)

Mechanisms and consequences of the loss of PHLPP1 phosphatase in chronic lymphocytic leukemia (CLL)
por: O'Hayre, M, et al.
Publicado: (2012)

Alemtuzumab in the treatment of fludarabine refractory B-cell chronic lymphocytic leukemia (CLL)
por: Montillo, Marco, et al.
Publicado: (2008)

Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017
por: Jakšić, Branimir, et al.
Publicado: (2018)

Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?
por: King, Rebecca L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_onm2rf55cmohmfote9803heglm